Sanhe (1)

B-cell Leukemia (1)

Completed (1)

phase 1 (1)

Hebei Yanda Ludaopei Hospital (1)

China Immunotech (Beijing) Biotechnology Co., Ltd. (1)

cd19/cd20 dual-car-t cells (1)

biological (1)

Other (1)

Interventional (1)

B-cell Leukemia

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Mar 6, 2022